CWM
ATYR

CIBC World Markets’s aTyr Pharma ATYR Stock Holding History

CIBC World Markets’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$54.3K Buy
+10,718
New +$42.2K ﹤0.01% 1467

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC World Markets's ATYR Position: Q2 2025 in Review

CIBC World Markets opened a new position in aTyr Pharma (ATYR) in Q2 2025: 10,718 shares worth $54.3K. The stake represents ﹤0.01% of the portfolio and ranks #1467 among its holdings.

110 funds tracked by Wall St. Rank hold ATYR as of Q2 2025.

  • CIBC World Markets held 10,718 shares of aTyr Pharma worth $54.3K as of Q2 2025.
  • aTyr Pharma was a new CIBC World Markets position in Q2 2025.
  • aTyr Pharma made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1467 holding.
  • 110 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.